{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T19:23:28Z","timestamp":1791487408844,"version":"4.3.4"},"reference-count":75,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2022,4,29]],"date-time":"2022-04-29T00:00:00Z","timestamp":1651190400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,4,29]],"date-time":"2022-04-29T00:00:00Z","timestamp":1651190400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["GeroScience"],"published-print":{"date-parts":[[2022,6]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    Vascular contribution to cognitive impairment and dementia (VCID) is a clinical label encompassing a wide range of cognitive disorders progressing from mild to major vascular cognitive impairment (VCI), which is also defined as vascular dementia (VaD). VaD diagnosis is mainly based on clinical and imaging findings. Earlier biomarkers are needed to identify subjects at risk to develop mild VCI and VaD. In the present meta-analysis, we comprehensively evaluated the role of inflammatory biomarkers in differential diagnosis between VaD and Alzheimer\u2019s disease (AD), and assessed their prognostic value on predicting VaD incidence. We collected literature until January 31, 2021, assessing three inflammatory markers [interleukin(IL)-6, C-reactive protein (CRP), tumor necrosis factor (TNF)-\u03b1] from blood or cerebrospinal fluid (CSF) samples. Thirteen cross-sectional and seven prospective studies were included. Blood IL-6 levels were cross-sectionally significantly higher in people with VaD compared to AD patients (SMD: 0.40, 95% CI: 0.18\u00a0to 0.62) with low heterogeneity (\n                    <jats:italic>I<\/jats:italic>\n                    <jats:sup>2<\/jats:sup>\n                    : 41%,\n                    <jats:italic>p<\/jats:italic>\n                    \u2009=\u20090.13). Higher IL-6 levels were also associated to higher risk of incident VaD (relative risk: 1.28, 95% CI: 1.03 to 1.59,\n                    <jats:italic>I<\/jats:italic>\n                    <jats:sup>2<\/jats:sup>\n                    : 0%). IL-6 in CSF was significantly higher in people with VaD compared to healthy subjects (SMD: 0.77, 95% CI: 0.17 to 1.37,\n                    <jats:italic>I<\/jats:italic>\n                    <jats:sup>2<\/jats:sup>\n                    : 70%), and not compared to AD patients, but due to limited evidence and high inconsistency across studies, we could not draw definite conclusion. Higher blood IL-6 levels might represent a useful biomarker able to differentiate people with VaD from those with AD and might be correlated with higher risk of future VaD.\n                  <\/jats:p>","DOI":"10.1007\/s11357-022-00556-w","type":"journal-article","created":{"date-parts":[[2022,4,29]],"date-time":"2022-04-29T10:10:05Z","timestamp":1651227005000},"page":"1373-1392","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":100,"title":["Role of inflammatory markers in the diagnosis of vascular contributions to cognitive impairment and dementia: a systematic review and meta-analysis"],"prefix":"10.1007","volume":"44","author":[{"given":"Carlo","family":"Custodero","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessandro","family":"Ciavarella","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesco","family":"Panza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Davide","family":"Gnocchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gennaro M.","family":"Lenato","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juhan","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonio","family":"Mazzocca","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlo","family":"Sabb\u00e0","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8524-0315","authenticated-orcid":false,"given":"Vincenzo","family":"Solfrizzi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,4,29]]},"reference":[{"issue":"3","key":"556_CR1","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1016\/j.jalz.2017.09.007","volume":"14","author":"OA Skrobot","year":"2018","unstructured":"Skrobot OA, Black SE, Chen C, DeCarli C, Erkinjuntti T, Ford GA, et al. Progress toward standardized diagnosis of vascular cognitive impairment: guidelines from the vascular impairment of cognition classification consensus study. Alzheimers Dement J Alzheimers Assoc. 2018;14(3):280\u201392. https:\/\/doi.org\/10.1016\/j.jalz.2017.09.007.","journal-title":"Alzheimers Dement J Alzheimers Assoc"},{"issue":"9","key":"556_CR2","doi-asserted-by":"publisher","first-page":"2672","DOI":"10.1161\/STR.0b013e3182299496","volume":"42","author":"PB Gorelick","year":"2011","unstructured":"Gorelick PB, Scuteri A, Black SE, Decarli C, Greenberg SM, Iadecola C, et al. Vascular contributions to cognitive impairment and dementia: a statement for healthcare professionals from the American Heart Association\/American Stroke Association. Stroke. 2011;42(9):2672\u2013713. https:\/\/doi.org\/10.1161\/STR.0b013e3182299496.","journal-title":"Stroke"},{"issue":"9","key":"556_CR3","doi-asserted-by":"publisher","first-page":"812","DOI":"10.1016\/S1474-4422(08)70169-8","volume":"7","author":"RN Kalaria","year":"2008","unstructured":"Kalaria RN, Maestre GE, Arizaga R, Friedland RP, Galasko D, Hall K, et al. Alzheimer\u2019s disease and vascular dementia in developing countries: prevalence, management, and risk factors. Lancet Neurol. 2008;7(9):812\u201326. https:\/\/doi.org\/10.1016\/S1474-4422(08)70169-8.","journal-title":"Lancet Neurol"},{"issue":"7","key":"556_CR4","doi-asserted-by":"publisher","first-page":"1487","DOI":"10.1161\/01.str.31.7.1487","volume":"31","author":"R Hebert","year":"2000","unstructured":"Hebert R, Lindsay J, Verreault R, Rockwood K, Hill G, Dubois MF. Vascular dementia\u202f: incidence and risk factors in the Canadian study of health and aging. Stroke. 2000;31(7):1487\u201393. https:\/\/doi.org\/10.1161\/01.str.31.7.1487.","journal-title":"Stroke"},{"issue":"3","key":"556_CR5","doi-asserted-by":"publisher","first-page":"573","DOI":"10.1161\/CIRCRESAHA.116.308426","volume":"120","author":"M Dichgans","year":"2017","unstructured":"Dichgans M, Leys D. Vascular cognitive impairment. Circ Res. 2017;120(3):573\u201391. https:\/\/doi.org\/10.1161\/CIRCRESAHA.116.308426.","journal-title":"Circ Res"},{"issue":"6","key":"556_CR6","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1042\/CS20160604","volume":"131","author":"GA Rosenberg","year":"2017","unstructured":"Rosenberg GA. Extracellular matrix inflammation in vascular cognitive impairment and dementia. Clin Sci. 2017;131(6):425\u201337. https:\/\/doi.org\/10.1042\/CS20160604.","journal-title":"Clin Sci"},{"key":"556_CR7","doi-asserted-by":"publisher","first-page":"333","DOI":"10.3389\/fnagi.2017.00333","volume":"9","author":"E Jaul","year":"2017","unstructured":"Jaul E, Meiron O. Systemic and disease-specific risk factors in vascular dementia: diagnosis and prevention. Front Aging Neurosci. 2017;9:333. https:\/\/doi.org\/10.3389\/fnagi.2017.00333.","journal-title":"Front Aging Neurosci"},{"issue":"4","key":"556_CR8","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1016\/j.jalz.2018.02.018","volume":"14","author":"CR Jack Jr","year":"2018","unstructured":"Jack CR Jr, Bennett DA, Blennow K, Carrillo MC, Dunn B, Haeberlein SB, et al. NIA-AA research framework: toward a biological definition of Alzheimer\u2019s disease. Alzheimers Dement J Alzheimers Assoc. 2018;14(4):535\u201362. https:\/\/doi.org\/10.1016\/j.jalz.2018.02.018.","journal-title":"Alzheimers Dement J Alzheimers Assoc"},{"key":"556_CR9","doi-asserted-by":"publisher","unstructured":"Wallin A Kapaki E Boban M Engelborghs S Hermann DM Huisa B et al. Biochemical markers in vascular cognitive impairment associated with subcortical small vessel disease - a consensus report. BMC Neurology. 2017;17(1). https:\/\/doi.org\/10.1186\/s12883-017-0877-3.","DOI":"10.1186\/s12883-017-0877-3"},{"issue":"9","key":"556_CR10","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1038\/s41569-018-0064-2","volume":"15","author":"L Ferrucci","year":"2018","unstructured":"Ferrucci L, Fabbri E. Inflammageing: chronic inflammation in ageing, cardiovascular disease, and frailty. Nat Rev Cardiol. 2018;15(9):505\u201322. https:\/\/doi.org\/10.1038\/s41569-018-0064-2.","journal-title":"Nat Rev Cardiol"},{"issue":"4","key":"556_CR11","doi-asserted-by":"publisher","first-page":"258","DOI":"10.1177\/1533317506289260","volume":"21","author":"T Dziedzic","year":"2006","unstructured":"Dziedzic T. Systemic inflammatory markers and risk of dementia. Am J Alzheimers Dis other Dement. 2006;21(4):258\u201362. https:\/\/doi.org\/10.1177\/1533317506289260.","journal-title":"Am J Alzheimers Dis other Dement"},{"issue":"11","key":"556_CR12","doi-asserted-by":"publisher","first-page":"1450","DOI":"10.1016\/j.jalz.2018.02.014","volume":"14","author":"SKL Darweesh","year":"2018","unstructured":"Darweesh SKL, Wolters FJ, Ikram MA, de Wolf F, Bos D, Hofman A. Inflammatory markers and the risk of dementia and Alzheimer\u2019s disease: a meta-analysis. Alzheimers Dement. 2018;14(11):1450\u20139. https:\/\/doi.org\/10.1016\/j.jalz.2018.02.014.","journal-title":"Alzheimers Dement"},{"issue":"4","key":"556_CR13","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1093\/gerona\/gls187","volume":"68","author":"A Koyama","year":"2013","unstructured":"Koyama A, O\u2019Brien J, Weuve J, Blacker D, Metti AL, Yaffe K. The role of peripheral inflammatory markers in dementia and Alzheimer\u2019s disease: a meta-analysis. J Gerontol A Biol Sci Med Sci. 2013;68(4):433\u201340. https:\/\/doi.org\/10.1093\/gerona\/gls187.","journal-title":"J Gerontol A Biol Sci Med Sci"},{"issue":"10","key":"556_CR14","doi-asserted-by":"publisher","first-page":"1006","DOI":"10.1016\/j.jclinepi.2009.06.005","volume":"62","author":"D Moher","year":"2009","unstructured":"Moher D, Liberati A, Tetzlaff J, Altman DG, Group P. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. J Clin Epidemiol. 2009;62(10):1006\u201312. https:\/\/doi.org\/10.1016\/j.jclinepi.2009.06.005.","journal-title":"J Clin Epidemiol"},{"issue":"6","key":"556_CR15","first-page":"727","volume":"18","author":"GA Wells","year":"2014","unstructured":"Wells GA, Shea BJ, O\u2019Connell D, Robertson J, Peterson J, Welch V, et al. The Newcastle-Ottawa Scale (NOS) for assessing the quality of non-randomized studies in meta-analysis. Appl Eng Agric. 2014;18(6):727\u201334.","journal-title":"Appl Eng Agric"},{"key":"556_CR16","doi-asserted-by":"publisher","DOI":"10.1002\/9780470743386","volume-title":"Introduction to meta-analysis","author":"M Borenstein","year":"2009","unstructured":"Borenstein M. Introduction to meta-analysis. Chichester, U.K.: John Wiley & Sons; 2009."},{"key":"556_CR17","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1186\/1471-2288-14-135","volume":"14","author":"X Wan","year":"2014","unstructured":"Wan X, Wang W, Liu J, Tong T. Estimating the sample mean and standard deviation from the sample size, median, range and\/or interquartile range. BMC Med Res Methodol. 2014;14:135. https:\/\/doi.org\/10.1186\/1471-2288-14-135.","journal-title":"BMC Med Res Methodol"},{"issue":"1","key":"556_CR18","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1037\/\/0033-2909.112.1.155","volume":"112","author":"J Cohen","year":"1992","unstructured":"Cohen J. A power primer. Psychol Bull. 1992;112(1):155\u20139. https:\/\/doi.org\/10.1037\/\/0033-2909.112.1.155.","journal-title":"Psychol Bull"},{"issue":"19","key":"556_CR19","first-page":"8519","volume":"28","author":"W Zhang","year":"2017","unstructured":"Zhang W, Lin Y, Lai J, Quan Y, Du Y, Li X. Correlation between brain magnetic resonance imaging and blood inflammatory markers for patients with vascular cognitive impairment. Biomed Res India. 2017;28(19):8519\u201324.","journal-title":"Biomed Res India"},{"issue":"3","key":"556_CR20","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1016\/j.clinbiochem.2015.10.014","volume":"49","author":"L Dukic","year":"2016","unstructured":"Dukic L, Simundic AM, Martinic-Popovic I, Kackov S, Diamandis A, Begcevic I, et al. The role of human kallikrein 6, clusterin and adiponectin as potential blood biomarkers of dementia. Clin Biochem. 2016;49(3):213\u20138. https:\/\/doi.org\/10.1016\/j.clinbiochem.2015.10.014.","journal-title":"Clin Biochem"},{"issue":"7","key":"556_CR21","doi-asserted-by":"publisher","first-page":"1554","DOI":"10.1007\/s11064-012-0750-0","volume":"37","author":"S Uslu","year":"2012","unstructured":"Uslu S, Akarkarasu ZE, Ozbabalik D, Ozkan S, Colak O, Demirkan ES, et al. Levels of amyloid beta-42, interleukin-6 and tumor necrosis factor-alpha in Alzheimer\u2019s disease and vascular dementia. Neurochem Res. 2012;37(7):1554\u20139. https:\/\/doi.org\/10.1007\/s11064-012-0750-0.","journal-title":"Neurochem Res"},{"issue":"3","key":"556_CR22","doi-asserted-by":"publisher","first-page":"241","DOI":"10.3109\/10715760903440153","volume":"44","author":"L Li","year":"2010","unstructured":"Li L, Willets RS, Polidori MC, Stahl W, Nelles G, Sies H, et al. Oxidative LDL modification is increased in vascular dementia and is inversely associated with cognitive performance. Free Radical Res. 2010;44(3):241\u20138. https:\/\/doi.org\/10.3109\/10715760903440153.","journal-title":"Free Radical Res"},{"issue":"1\u20132","key":"556_CR23","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1016\/j.neulet.2005.03.051","volume":"383","author":"JP Jia","year":"2005","unstructured":"Jia JP, Meng R, Sun YX, Sun WJ, Ji XM, Jia LF. Cerebrospinal fluid tau, A beta(1\u201342) and inflammatory cytokines in patients with Alzheimer\u2019s disease and vascular dementia. Neurosci Lett. 2005;383(1\u20132):12\u20136. https:\/\/doi.org\/10.1016\/j.neulet.2005.03.051.","journal-title":"Neurosci Lett"},{"issue":"2","key":"556_CR24","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1111\/j.1600-0404.2004.00286.x","volume":"110","author":"K Wada-Isoe","year":"2004","unstructured":"Wada-Isoe K, Wakutani Y, Urakami K, Nakashima K. Elevated interleukin-6 levels in cerebrospinal fluid of vascular dementia patients. Acta Neurol Scand. 2004;110(2):124\u20137. https:\/\/doi.org\/10.1111\/j.1600-0404.2004.00286.x.","journal-title":"Acta Neurol Scand"},{"issue":"2\u20133","key":"556_CR25","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1016\/S0531-5565(01)00191-7","volume":"37","author":"R Paganelli","year":"2002","unstructured":"Paganelli R, Di Iorio A, Patricelli L, Ripani F, Sparvieri E, Faricelli R, et al. Proinflammatory cytokines in sera of elderly patients with dementia: levels in vascular injury are higher than those of mild-moderate Alzheimer\u2019s disease patients. Exp Gerontol. 2002;37(2\u20133):257\u201363. https:\/\/doi.org\/10.1016\/S0531-5565(01)00191-7.","journal-title":"Exp Gerontol"},{"issue":"16","key":"556_CR26","doi-asserted-by":"publisher","first-page":"1985","DOI":"10.1016\/S0047-6374(01)00313-X","volume":"122","author":"A De Luigi","year":"2001","unstructured":"De Luigi A, Fragiacomo C, Lucca U, Quadri P, Tettamanti M, De Simoni MG. Inflammatory markers in Alzheimer\u2019s disease and multi-infarct dementia. Mech Ageing Dev. 2001;122(16):1985\u201395.","journal-title":"Mech Ageing Dev"},{"issue":"8","key":"556_CR27","doi-asserted-by":"publisher","first-page":"686","DOI":"10.1016\/j.jpsychires.2006.02.008","volume":"41","author":"G Zuliani","year":"2007","unstructured":"Zuliani G, Ranzini M, Guerra G, Rossi L, Munari MR, Zurlo A, et al. Plasma cytokines profile in older subjects with late onset Alzheimer\u2019s disease or vascular dementia. J Psychiatr Res. 2007;41(8):686\u201393. https:\/\/doi.org\/10.1016\/j.jpsychires.2006.02.008.","journal-title":"J Psychiatr Res"},{"issue":"4","key":"556_CR28","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1023\/a:1020568013953","volume":"19","author":"E Tarkowski","year":"1999","unstructured":"Tarkowski E, Blennow K, Wallin A, Tarkowski A. Intracerebral production of tumor necrosis factor-alpha, a local neuroprotective agent, in Alzheimer disease and vascular dementia. J Clin Immunol. 1999;19(4):223\u201330. https:\/\/doi.org\/10.1023\/a:1020568013953.","journal-title":"J Clin Immunol"},{"issue":"3","key":"556_CR29","doi-asserted-by":"publisher","first-page":"169","DOI":"10.5114\/ppn.2019.89127","volume":"28","author":"H Wehr","year":"2019","unstructured":"Wehr H, \u0141ugowska A, Graban A, Wi\u015bniewska A, Hetma\u0144czyk-Sawicka K, Witkowski G, et al. Carotid atherosclerosis and dementia \u2013 inflammatory markers and marker of macrophage activation. Postepy Psychiatrii i Neurologii. 2019;28(3):169\u201375. https:\/\/doi.org\/10.5114\/ppn.2019.89127.","journal-title":"Postepy Psychiatrii i Neurologii"},{"key":"556_CR30","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1016\/j.ajp.2017.04.015","volume":"29","author":"VY Vishnu","year":"2017","unstructured":"Vishnu VY, Modi M, Garg VK, Mohanty M, Goyal MK, Lal V, et al. Role of inflammatory and hemostatic biomarkers in Alzheimer\u2019s and vascular dementia \u2013 a pilot study from a tertiary center in Northern India. Asian J Psychiatr. 2017;29:59\u201362. https:\/\/doi.org\/10.1016\/j.ajp.2017.04.015.","journal-title":"Asian J Psychiatr"},{"issue":"Suppl 1","key":"556_CR31","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1016\/j.archger.2009.09.028","volume":"49","author":"A Mancinella","year":"2009","unstructured":"Mancinella A, Mancinella M, Carpinteri G, Bellomo A, Fossati C, Gianturco V, et al. Is there a relationship between high C-reactive protein (CRP) levels and dementia? Arch Gerontol Geriatr. 2009;49(Suppl 1):185\u201394. https:\/\/doi.org\/10.1016\/j.archger.2009.09.028.","journal-title":"Arch Gerontol Geriatr"},{"issue":"3","key":"556_CR32","doi-asserted-by":"publisher","first-page":"656","DOI":"10.1111\/ene.12921","volume":"23","author":"K Miwa","year":"2016","unstructured":"Miwa K, Okazaki S, Sakaguchi M, Mochizuki H, Kitagawa K. Interleukin-6, interleukin-6 receptor gene variant, small-vessel disease and incident dementia. Eur J Neurol. 2016;23(3):656\u201363. https:\/\/doi.org\/10.1111\/ene.12921.","journal-title":"Eur J Neurol"},{"issue":"3","key":"556_CR33","doi-asserted-by":"publisher","first-page":"599","DOI":"10.1161\/ATVBAHA.109.197368","volume":"30","author":"J Gallacher","year":"2010","unstructured":"Gallacher J, Bayer A, Lowe G, Fish M, Pickering J, Pedro S, et al. Is sticky blood bad for the brain?: hemostatic and inflammatory systems and dementia in the caerphilly prospective study. Arterioscler Thromb Vasc Biol. 2010;30(3):599\u2013604. https:\/\/doi.org\/10.1161\/ATVBAHA.109.197368.","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"12","key":"556_CR34","doi-asserted-by":"publisher","first-page":"1810","DOI":"10.1016\/j.neurobiolaging.2006.08.012","volume":"28","author":"G Ravaglia","year":"2007","unstructured":"Ravaglia G, Forti P, Maioli F, Chiappelli M, Montesi F, Tumini E, et al. Blood inflammatory markers and risk of dementia: The Conselice study of brain aging. Neurobiol Aging. 2007;28(12):1810\u201320. https:\/\/doi.org\/10.1016\/j.neurobiolaging.2006.08.012.","journal-title":"Neurobiol Aging"},{"issue":"5","key":"556_CR35","doi-asserted-by":"publisher","first-page":"668","DOI":"10.1001\/archneur.61.5.668","volume":"61","author":"MJ Engelhart","year":"2004","unstructured":"Engelhart MJ, Geerlings MI, Meijer J, Kiliaan A, Ruitenberg A, Van Swieten JC, et al. Inflammatory proteins in plasma and the risk of dementia: the Rotterdam study. Arch Neurol. 2004;61(5):668\u201372. https:\/\/doi.org\/10.1001\/archneur.61.5.668.","journal-title":"Arch Neurol"},{"issue":"2","key":"556_CR36","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1002\/ana.10265","volume":"52","author":"R Schmidt","year":"2002","unstructured":"Schmidt R, Schmidt H, Curb JD, Masaki K, White LR, Launer LJ. Early inflammation and dementia: a 25-year follow-up of the Honolulu-Asia Aging Study. Ann Neurol. 2002;52(2):168\u201374. https:\/\/doi.org\/10.1002\/ana.10265.","journal-title":"Ann Neurol"},{"issue":"3","key":"556_CR37","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1016\/j.jamda.2016.12.006","volume":"18","author":"PF Hsu","year":"2017","unstructured":"Hsu PF, Pan WH, Yip BS, Chen RCY, Cheng HM, Chuang SY. C-reactive protein predicts incidence of dementia in an elderly Asian community cohort. J Am Med Dir Assoc. 2017;18(3):277-e7 e11.","journal-title":"J Am Med Dir Assoc"},{"issue":"12","key":"556_CR38","doi-asserted-by":"publisher","first-page":"2637","DOI":"10.1161\/01.STR.0000189721.31432.26","volume":"36","author":"M Van Oijen","year":"2005","unstructured":"Van Oijen M, Witteman JC, Hofman A, Koudstaal PJ, Breteler MMB. Fibrinogen is associated with an increased risk of Alzheimer disease and vascular dementia. Stroke. 2005;36(12):2637\u201341. https:\/\/doi.org\/10.1161\/01.STR.0000189721.31432.26.","journal-title":"Stroke"},{"issue":"1","key":"556_CR39","doi-asserted-by":"publisher","first-page":"12050","DOI":"10.1038\/s41598-018-30487-6","volume":"8","author":"A Ng","year":"2018","unstructured":"Ng A, Tam WW, Zhang MW, Ho CS, Husain SF, McIntyre RS, et al. IL-1beta, IL-6, TNF- alpha and CRP in elderly patients with depression or Alzheimer\u2019s disease: systematic review and meta-analysis. Sci Rep. 2018;8(1):12050. https:\/\/doi.org\/10.1038\/s41598-018-30487-6.","journal-title":"Sci Rep"},{"issue":"1","key":"556_CR40","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1016\/j.jstrokecerebrovasdis.2005.08.009","volume":"15","author":"CB Wright","year":"2006","unstructured":"Wright CB, Sacco RL, Rundek TR, Delman JB, Rabbani LE, Elkind MSV. Interleukin-6 is associated with cognitive function: the Northern Manhattan study. J Stroke Cerebrovasc Dis. 2006;15(1):34\u20138. https:\/\/doi.org\/10.1016\/j.jstrokecerebrovasdis.2005.08.009.","journal-title":"J Stroke Cerebrovasc Dis"},{"key":"556_CR41","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1186\/s12979-016-0076-x","volume":"13","author":"M Puzianowska-Kuznicka","year":"2016","unstructured":"Puzianowska-Kuznicka M, Owczarz M, Wieczorowska-Tobis K, Nadrowski P, Chudek J, Slusarczyk P, et al. Interleukin-6 and C-reactive protein, successful aging, and mortality: the PolSenior study. Immun ageing\u202f: I & A. 2016;13:21. https:\/\/doi.org\/10.1186\/s12979-016-0076-x.","journal-title":"Immun ageing : I & A"},{"issue":"11","key":"556_CR42","doi-asserted-by":"publisher","first-page":"3038","DOI":"10.1016\/j.neurobiolaging.2015.07.025","volume":"36","author":"AL Metti","year":"2015","unstructured":"Metti AL, Aizenstein H, Yaffe K, Boudreau RM, Newman A, Launer L, et al. Trajectories of peripheral interleukin-6, structure of the hippocampus, and cognitive impairment over 14 years in older adults. Neurobiol Aging. 2015;36(11):3038\u201344. https:\/\/doi.org\/10.1016\/j.neurobiolaging.2015.07.025.","journal-title":"Neurobiol Aging"},{"issue":"4","key":"556_CR43","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1159\/000343276","volume":"40","author":"A Economos","year":"2013","unstructured":"Economos A, Wright CB, Moon YP, Rundek T, Rabbani L, Paik MC, et al. Interleukin 6 plasma concentration associates with cognitive decline: the northern Manhattan study. Neuroepidemiology. 2013;40(4):253\u20139. https:\/\/doi.org\/10.1159\/000343276.","journal-title":"Neuroepidemiology"},{"issue":"1","key":"556_CR44","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1097\/00062752-200701000-00011","volume":"14","author":"K Croce","year":"2007","unstructured":"Croce K, Libby P. Intertwining of thrombosis and inflammation in atherosclerosis. Curr Opin Hematol. 2007;14(1):55\u201361. https:\/\/doi.org\/10.1097\/00062752-200701000-00011.","journal-title":"Curr Opin Hematol"},{"issue":"11","key":"556_CR45","doi-asserted-by":"publisher","first-page":"1877","DOI":"10.1016\/j.neurobiolaging.2008.10.012","volume":"31","author":"P Buchhave","year":"2010","unstructured":"Buchhave P, Zetterberg H, Blennow K, Minthon L, Janciauskiene S, Hansson O. Soluble TNF receptors are associated with Abeta metabolism and conversion to dementia in subjects with mild cognitive impairment. Neurobiol Aging. 2010;31(11):1877\u201384. https:\/\/doi.org\/10.1016\/j.neurobiolaging.2008.10.012.","journal-title":"Neurobiol Aging"},{"key":"556_CR46","doi-asserted-by":"publisher","unstructured":"Llorens F Schmitz M Knipper T Schmidt C Lange P Fischer A et al. Cerebrospinal fluid biomarkers of Alzheimer\u2019s disease show different but partially overlapping profile compared to vascular dementia. Frontiers in Aging Neuroscience. 2017;9(SEP). https:\/\/doi.org\/10.3389\/fnagi.2017.00289.","DOI":"10.3389\/fnagi.2017.00289"},{"issue":"1","key":"556_CR47","doi-asserted-by":"publisher","first-page":"45","DOI":"10.3233\/JAD-2012-120787","volume":"33","author":"B Olsson","year":"2013","unstructured":"Olsson B, Hertze J, Lautner R, Zetterberg H, Nagga K, Hoglund K, et al. Microglial markers are elevated in the prodromal phase of Alzheimer\u2019s disease and vascular dementia. J Alzheimers Dis. 2013;33(1):45\u201353. https:\/\/doi.org\/10.3233\/JAD-2012-120787.","journal-title":"J Alzheimers Dis"},{"key":"556_CR48","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1016\/j.neurobiolaging.2015.10.021","volume":"38","author":"A Chen","year":"2016","unstructured":"Chen A, Oakley AE, Monteiro M, Tuomela K, Allan LM, Mukaetova-Ladinska EB, et al. Multiplex analyte assays to characterize different dementias: brain inflammatory cytokines in poststroke and other dementias. Neurobiol Aging. 2016;38:56\u201367. https:\/\/doi.org\/10.1016\/j.neurobiolaging.2015.10.021.","journal-title":"Neurobiol Aging"},{"issue":"3","key":"556_CR49","doi-asserted-by":"publisher","first-page":"278","DOI":"10.1159\/000118633","volume":"25","author":"E Mulugeta","year":"2008","unstructured":"Mulugeta E, Molina-Holgado F, Elliott MS, Hortobagyi T, Perry R, Kalaria RN, et al. Inflammatory mediators in the frontal lobe of patients with mixed and vascular dementia. Dement Geriatr Cogn Disord. 2008;25(3):278\u201386. https:\/\/doi.org\/10.1159\/000118633.","journal-title":"Dement Geriatr Cogn Disord"},{"key":"556_CR50","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1016\/j.jneuroim.2018.04.004","volume":"320","author":"M Belkhelfa","year":"2018","unstructured":"Belkhelfa M, Beder N, Mouhoub D, Amri M, Hayet R, Tighilt N, et al. The involvement of neuroinflammation and necroptosis in the hippocampus during vascular dementia. J Neuroimmunol. 2018;320:48\u201357. https:\/\/doi.org\/10.1016\/j.jneuroim.2018.04.004.","journal-title":"J Neuroimmunol"},{"key":"556_CR51","doi-asserted-by":"publisher","unstructured":"Low A Mak E Rowe JB Markus HS O\u2019Brien JT. Inflammation and cerebral small vessel disease: a systematic review. Ageing Research Reviews. 2019;53. https:\/\/doi.org\/10.1016\/j.arr.2019.100916.","DOI":"10.1016\/j.arr.2019.100916"},{"key":"556_CR52","doi-asserted-by":"publisher","unstructured":"Moretti R Caruso P. Small vessel disease-related dementia: an invalid neurovascular coupling? International Journal of Molecular Sciences. 2020;21(3). https:\/\/doi.org\/10.3390\/ijms21031095.","DOI":"10.3390\/ijms21031095"},{"issue":"1","key":"556_CR53","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1161\/ATVBAHA.111.236349","volume":"32","author":"Y Song","year":"2012","unstructured":"Song Y, Shen H, Schenten D, Shan P, Lee PJ, Goldstein DR. Aging enhances the basal production of IL-6 and CCL2 in vascular smooth muscle cells. Arterioscler Thromb Vasc Biol. 2012;32(1):103\u20139. https:\/\/doi.org\/10.1161\/ATVBAHA.111.236349.","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"6","key":"556_CR54","doi-asserted-by":"publisher","first-page":"805","DOI":"10.1111\/j.1474-9726.2008.00438.x","volume":"7","author":"AJ Donato","year":"2008","unstructured":"Donato AJ, Black AD, Jablonski KL, Gano LB, Seals DR. Aging is associated with greater nuclear NF kappa B, reduced I kappa B alpha, and increased expression of proinflammatory cytokines in vascular endothelial cells of healthy humans. Aging Cell. 2008;7(6):805\u201312. https:\/\/doi.org\/10.1111\/j.1474-9726.2008.00438.x.","journal-title":"Aging Cell"},{"issue":"7","key":"556_CR55","doi-asserted-by":"publisher","first-page":"849","DOI":"10.1161\/circresaha.118.311378","volume":"123","author":"Z Ungvari","year":"2018","unstructured":"Ungvari Z, Tarantini S, Donato AJ, Galvan V, Csiszar A. Mechanisms of vascular aging. Circ Res. 2018;123(7):849\u201367. https:\/\/doi.org\/10.1161\/circresaha.118.311378.","journal-title":"Circ Res"},{"issue":"5","key":"556_CR56","doi-asserted-by":"publisher","first-page":"860","DOI":"10.1016\/j.bbadis.2015.12.015","volume":"1862","author":"PB Gorelick","year":"2016","unstructured":"Gorelick PB, Counts SE, Nyenhuis D. Vascular cognitive impairment and dementia. Biochem Biophys Acta. 2016;1862(5):860\u20138. https:\/\/doi.org\/10.1016\/j.bbadis.2015.12.015.","journal-title":"Biochem Biophys Acta"},{"key":"556_CR57","doi-asserted-by":"crossref","unstructured":"Sim FJ Zhao C Penderis J Franklin RJ. The age-related decrease in CNS remyelination efficiency is attributable to an impairment of both oligodendrocyte progenitor recruitment and differentiation. The Journal of neuroscience : the official journal of the Society for Neuroscience. 2002;22(7):2451\u20139. 20026217.","DOI":"10.1523\/JNEUROSCI.22-07-02451.2002"},{"issue":"7","key":"556_CR58","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1016\/j.tips.2008.05.003","volume":"29","author":"C Marchesi","year":"2008","unstructured":"Marchesi C, Paradis P, Schiffrin EL. Role of the renin-angiotensin system in vascular inflammation. Trends Pharmacol Sci. 2008;29(7):367\u201374. https:\/\/doi.org\/10.1016\/j.tips.2008.05.003.","journal-title":"Trends Pharmacol Sci"},{"issue":"12","key":"556_CR59","doi-asserted-by":"publisher","first-page":"686","DOI":"10.1038\/nrcardio.2010.161","volume":"7","author":"V Novak","year":"2010","unstructured":"Novak V, Hajjar I. The relationship between blood pressure and cognitive function. Nat Rev Cardiol. 2010;7(12):686\u201398. https:\/\/doi.org\/10.1038\/nrcardio.2010.161.","journal-title":"Nat Rev Cardiol"},{"issue":"3","key":"556_CR60","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1097\/CRD.0000000000000021","volume":"22","author":"J Hartman","year":"2014","unstructured":"Hartman J, Frishman WH. Inflammation and atherosclerosis: a review of the role of interleukin-6 in the development of atherosclerosis and the potential for targeted drug therapy. Cardiol Rev. 2014;22(3):147\u201351. https:\/\/doi.org\/10.1097\/CRD.0000000000000021.","journal-title":"Cardiol Rev"},{"issue":"1","key":"556_CR61","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1007\/s11373-004-8170-z","volume":"12","author":"BS Wung","year":"2005","unstructured":"Wung BS, Ni CW, Wang DL. ICAM-1 induction by TNFalpha and IL-6 is mediated by distinct pathways via Rac in endothelial cells. J Biomed Sci. 2005;12(1):91\u2013101. https:\/\/doi.org\/10.1007\/s11373-004-8170-z.","journal-title":"J Biomed Sci"},{"issue":"1","key":"556_CR62","doi-asserted-by":"publisher","first-page":"8027","DOI":"10.1038\/s41598-020-64998-y","volume":"10","author":"H Holm","year":"2020","unstructured":"Holm H, Nagga K, Nilsson ED, Ricci F, Melander O, Hansson O, et al. High circulating levels of midregional proenkephalin A predict vascular dementia: a population-based prospective study. Sci Rep. 2020;10(1):8027. https:\/\/doi.org\/10.1038\/s41598-020-64998-y.","journal-title":"Sci Rep"},{"issue":"17","key":"556_CR63","doi-asserted-by":"publisher","first-page":"2184","DOI":"10.1161\/01.cir.0000037521.71373.44","volume":"106","author":"D Hurlimann","year":"2002","unstructured":"Hurlimann D, Forster A, Noll G, Enseleit F, Chenevard R, Distler O, et al. Anti-tumor necrosis factor-alpha treatment improves endothelial function in patients with rheumatoid arthritis. Circulation. 2002;106(17):2184\u20137. https:\/\/doi.org\/10.1161\/01.cir.0000037521.71373.44.","journal-title":"Circulation"},{"issue":"2","key":"556_CR64","doi-asserted-by":"publisher","first-page":"734","DOI":"10.1016\/j.atherosclerosis.2011.09.015","volume":"219","author":"AD Protogerou","year":"2011","unstructured":"Protogerou AD, Zampeli E, Fragiadaki K, Stamatelopoulos K, Papamichael C, Sfikakis PP. A pilot study of endothelial dysfunction and aortic stiffness after interleukin-6 receptor inhibition in rheumatoid arthritis. Atherosclerosis. 2011;219(2):734\u20136. https:\/\/doi.org\/10.1016\/j.atherosclerosis.2011.09.015.","journal-title":"Atherosclerosis"},{"issue":"26","key":"556_CR65","doi-asserted-by":"publisher","first-page":"2497","DOI":"10.1056\/NEJMoa1912388","volume":"381","author":"JC Tardif","year":"2019","unstructured":"Tardif JC, Kouz S, Waters DD, Bertrand OF, Diaz R, Maggioni AP, et al. Efficacy and safety of low-dose colchicine after myocardial infarction. N Engl J Med. 2019;381(26):2497\u2013505. https:\/\/doi.org\/10.1056\/NEJMoa1912388.","journal-title":"N Engl J Med"},{"issue":"8","key":"556_CR66","doi-asserted-by":"publisher","first-page":"752","DOI":"10.1056\/NEJMoa1809798","volume":"380","author":"PM Ridker","year":"2019","unstructured":"Ridker PM, Everett BM, Pradhan A, MacFadyen JG, Solomon DH, Zaharris E, et al. Low-dose methotrexate for the prevention of atherosclerotic events. N Engl J Med. 2019;380(8):752\u201362. https:\/\/doi.org\/10.1056\/NEJMoa1809798.","journal-title":"N Engl J Med"},{"issue":"12","key":"556_CR67","doi-asserted-by":"publisher","first-page":"1119","DOI":"10.1056\/NEJMoa1707914","volume":"377","author":"PM Ridker","year":"2017","unstructured":"Ridker PM, Everett BM, Thuren T, MacFadyen JG, Chang WH, Ballantyne C, et al. Antiinflammatory therapy with canakinumab for atherosclerotic disease. N Engl J Med. 2017;377(12):1119\u201331. https:\/\/doi.org\/10.1056\/NEJMoa1707914.","journal-title":"N Engl J Med"},{"issue":"5","key":"556_CR68","doi-asserted-by":"publisher","first-page":"729","DOI":"10.1161\/01.ATV.0000063385.12476.A7","volume":"23","author":"S Wolfrum","year":"2003","unstructured":"Wolfrum S, Jensen KS, Liao JK. Endothelium-dependent effects of statins. Arterioscler Thromb Vasc Biol. 2003;23(5):729\u201336. https:\/\/doi.org\/10.1161\/01.ATV.0000063385.12476.A7.","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"2","key":"556_CR69","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1136\/hrt.2006.093112","volume":"93","author":"D Tousoulis","year":"2007","unstructured":"Tousoulis D, Antoniades C, Vasiliadou C, Kourtellaris P, Koniari K, Marinou K, et al. Effects of atorvastatin and vitamin C on forearm hyperaemic blood flow, asymmentrical dimethylarginine levels and the inflammatory process in patients with type 2 diabetes mellitus. Heart. 2007;93(2):244\u20136. https:\/\/doi.org\/10.1136\/hrt.2006.093112.","journal-title":"Heart"},{"issue":"1","key":"556_CR70","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1001\/jama.286.1.64","volume":"286","author":"MA Albert","year":"2001","unstructured":"Albert MA, Danielson E, Rifai N, Ridker PM, Investigators P. Effect of statin therapy on C-reactive protein levels: the pravastatin inflammation\/CRP evaluation (PRINCE): a randomized trial and cohort study. JAMA. 2001;286(1):64\u201370. https:\/\/doi.org\/10.1001\/jama.286.1.64.","journal-title":"JAMA"},{"issue":"21","key":"556_CR71","doi-asserted-by":"publisher","first-page":"2195","DOI":"10.1056\/NEJMoa0807646","volume":"359","author":"PM Ridker","year":"2008","unstructured":"Ridker PM, Danielson E, Fonseca FA, Genest J, Gotto AM Jr, Kastelein JJ, et al. Rosuvastatin to prevent vascular events in men and women with elevated C-reactive protein. N Engl J Med. 2008;359(21):2195\u2013207. https:\/\/doi.org\/10.1056\/NEJMoa0807646.","journal-title":"N Engl J Med"},{"issue":"Suppl 3","key":"556_CR72","doi-asserted-by":"publisher","first-page":"S315","DOI":"10.3233\/JAD-132366","volume":"42","author":"S Giannopoulos","year":"2014","unstructured":"Giannopoulos S, Katsanos AH, Kosmidou M, Tsivgoulis G. Statins and vascular dementia: a review. J Alzheimers Dis. 2014;42(Suppl 3):S315\u201320. https:\/\/doi.org\/10.3233\/JAD-132366.","journal-title":"J Alzheimers Dis"},{"issue":"1","key":"556_CR73","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1124\/jpet.118.254854","volume":"369","author":"M Hay","year":"2019","unstructured":"Hay M, Polt R, Heien ML, Vanderah TW, Largent-Milnes TM, Rodgers K, et al. A novel angiotensin-(1\u20137) glycosylated MAs receptor agonist for treating vascular cognitive impairment and inflammation-related memory dysfunction. J Pharmacol Exp Ther. 2019;369(1):9\u201325. https:\/\/doi.org\/10.1124\/jpet.118.254854.","journal-title":"J Pharmacol Exp Ther"},{"key":"556_CR74","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1016\/j.nbd.2019.01.007","volume":"125","author":"D Impellizzeri","year":"2019","unstructured":"Impellizzeri D, Siracusa R, Cordaro M, Crupi R, Peritore AF, Gugliandolo E, et al. N-Palmitoylethanolamine-oxazoline (PEA-OXA): a new therapeutic strategy to reduce neuroinflammation, oxidative stress associated to vascular dementia in an experimental model of repeated bilateral common carotid arteries occlusion. Neurobiol Dis. 2019;125:77\u201391. https:\/\/doi.org\/10.1016\/j.nbd.2019.01.007.","journal-title":"Neurobiol Dis"},{"key":"556_CR75","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1016\/j.physbeh.2018.12.012","volume":"201","author":"SS Gocmez","year":"2019","unstructured":"Gocmez SS, Sahin TD, Yazir Y, Duruksu G, Eraldemir FC, Polat S, et al. Resveratrol prevents cognitive deficits by attenuating oxidative damage and inflammation in rat model of streptozotocin diabetes induced vascular dementia. Physiol Behav. 2019;201:198\u2013207. https:\/\/doi.org\/10.1016\/j.physbeh.2018.12.012.","journal-title":"Physiol Behav"}],"container-title":["GeroScience"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11357-022-00556-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11357-022-00556-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11357-022-00556-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,7,25]],"date-time":"2022-07-25T06:27:00Z","timestamp":1658730420000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11357-022-00556-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,4,29]]},"references-count":75,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2022,6]]}},"alternative-id":["556"],"URL":"https:\/\/doi.org\/10.1007\/s11357-022-00556-w","relation":{},"ISSN":["2509-2715","2509-2723"],"issn-type":[{"value":"2509-2715","type":"print"},{"value":"2509-2723","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,4,29]]},"assertion":[{"value":"6 September 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 March 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 April 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 July 2022","order":4,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Update","order":5,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Missing Open Access funding information has been added in the Funding Note.","order":6,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}